About Eagle Genomics
Eagle Genomics is a company based in Cambridge (United Kingdom) founded in 2008.. Eagle Genomics has raised $38.73 million across 9 funding rounds from investors including Gov.uk, Newable and abrdn. Eagle Genomics offers products and services including e[datascientist], e[exploration], e[biology], e[datascience], and e[sdk]. Eagle Genomics operates in a competitive market with competitors including DNAnexus, Genomics, Depixus, Seven Bridges Genomics and Ingenuity Systems, among others.
- Headquarter Cambridge, United Kingdom
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Eagle Genomics Limited
- Date of Incorporation 07 May, 2008
- Jurisdiction CAMBRIDGE, CAMBRIDGESHIRE, ENGLAND
-
Annual Revenue
$3.35 M (USD)79as on Mar 31, 2022
-
Net Profit
$-6.88 M (USD)-101as on Mar 31, 2022
-
EBITDA
$-6.88 M (USD)-101as on Mar 31, 2022
-
Total Equity Funding
$38.73 M (USD)
in 9 rounds
-
Latest Funding Round
$3.65 M (USD), Series C
Sep 27, 2023
-
Investors
Gov.uk
& 11 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Eagle Genomics
Eagle Genomics offers a comprehensive portfolio of products and services, including e[datascientist], e[exploration], e[biology], e[datascience], and e[sdk]. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for analyzing microbiome data to drive innovation.
Tool for exploring complex microbiome patterns and relationships.
Service for biological data integration in microbiome research.
Application for advanced data science in microbiome contexts.
Kit for developing custom microbiome data applications.
Platform for sharing and accessing microbiome data resources.
Tool for detailed reporting on microbial strains and networks.
Unlock access to complete
Unlock access to complete
Funding Insights of Eagle Genomics
Eagle Genomics has successfully raised a total of $38.73M across 9 strategic funding rounds. The most recent funding activity was a Series C round of $3.65 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series C — $3.7M
-
First Round
First Round
(04 Sep 2013)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Series C - Eagle Genomics | Valuation | ETF Partners | |
| Oct, 2022 | Amount | Series C - Eagle Genomics | Valuation | abrdn | |
| Oct, 2020 | Amount | Series B - Eagle Genomics | Valuation | ETF Partners , Granpool |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Eagle Genomics
Eagle Genomics has secured backing from 12 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Gov.uk, Newable and abrdn. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments in tech and energy sectors are targeted.
|
Founded Year | Domain | Location | |
|
Granpool is recognized as a venture capital investment firm.
|
Founded Year | Domain | Location | |
|
Multiple sectors are invested in by abrdn's private equity fund.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Eagle Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Eagle Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Eagle Genomics Comparisons
Competitors of Eagle Genomics
Eagle Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Genomics, Depixus, Seven Bridges Genomics and Ingenuity Systems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud-based genome informatics and data management are provided.
|
|
| domain | founded_year | HQ Location |
Genomic risk assessment and prevention platform is provided.
|
|
| domain | founded_year | HQ Location |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| domain | founded_year | HQ Location |
Genomic data is analyzed and interpreted via web-based applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Eagle Genomics
Frequently Asked Questions about Eagle Genomics
When was Eagle Genomics founded?
Eagle Genomics was founded in 2008 and raised its 1st funding round 5 years after it was founded.
Where is Eagle Genomics located?
Eagle Genomics is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Who is the current CEO of Eagle Genomics?
Anthony Finbow is the current CEO of Eagle Genomics.
Is Eagle Genomics a funded company?
Eagle Genomics is a funded company, having raised a total of $38.73M across 9 funding rounds to date. The company's 1st funding round was a Series B of $9M, raised on Sep 04, 2013.
What is the annual revenue of Eagle Genomics?
Annual revenue of Eagle Genomics is $3.35M as on Mar 31, 2022.
What does Eagle Genomics do?
Eagle Genomics was founded in 2008 and is based in Cambridge, United Kingdom. Cloud-based software solutions for genomic analysis are provided by the company within the biotechnology sector. Operations focus on platforms such as Eaglecore, which supports collaborative information management in research and development, and EagleEnsembl, which enables searching and analysis of genomic data. Services are delivered through a domain at eaglegenomics.com.
Who are the top competitors of Eagle Genomics?
Eagle Genomics's top competitors include DNAnexus, Depixus and Ingenuity Systems.
What products or services does Eagle Genomics offer?
Eagle Genomics offers e[datascientist], e[exploration], e[biology], e[datascience], and 3 more products and services.
Who are Eagle Genomics's investors?
Eagle Genomics has 12 investors. Key investors include Gov.uk, Newable, abrdn, ETF Partners, and Granpool.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.